Sweta Srivastava
- Cell Biology top 5%
-
- Epigenetics and DNA Methylation 2
- RNA Interference and Gene Delivery 2
-
- Cancer Cells and Metastasis 5
- Cancer-related Molecular Pathways 3
-
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 2
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
-
- Nanoparticle-Based Drug Delivery 2
- Co-authors
- Cecil RossJohanne MathesonAndrew B. FieldingRytis PrekerisXinzi YuStephen A. BaldwinGilles R.X. HicksonGwyn W. Gould
- Journals
- Journal of Experimental & Clinical Cancer Research (2 papers)Cancer Research (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Sweta Srivastava
23 papers receiving 651 citations
Peers
Comparison fields: 5 of 89
- Cell Biology 260
- Cancer Research 92
- Molecular Biology 416
- Physiology 24
- Oncology 116
Countries citing papers authored by Sweta Srivastava
This map shows the geographic impact of Sweta Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sweta Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sweta Srivastava more than expected).
Fields of papers citing papers by Sweta Srivastava
This network shows the impact of papers produced by Sweta Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sweta Srivastava. The network helps show where Sweta Srivastava may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sweta Srivastava, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2022 | 3 | |
| 3 | 2021 | 1 | |
| 4 | 2021 | 2 | |
| 5 | 2020 | 6 | |
| 6 | 2019 | 21 | |
| 7 | 2019 | 44 | |
| 8 | 2019 | 27 | |
| 9 | 2019 | 34 | |
| 10 | 2016 | 31 | |
| 11 | 2016 | 23 | |
| 12 | 2016 | 13 | |
| 13 | 2014 | 7 | |
| 14 | Presence of the ASN680SER Polymorphism in women with Primary Amenorrhea from South India | 2014 | 1 |
| 15 | 2011 | 32 | |
| 16 | 2009 | 53 | |
| 17 | Cancer stem cells: an approach to identify newer therapeutic targets. | 2009 | 6 |
| 18 | A non-invasive technique for rapid extraction of DNA from fish scales. | 2007 | 33 |
| 19 | 2005 | 264 | |
| 20 | 2005 | 57 |
About Sweta Srivastava
Sweta Srivastava is a scholar working on Genetics, Hematology and Oncology, having authored 23 papers that have together received 668 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Cancer-related Molecular Pathways (3 papers), Acute Myeloid Leukemia Research (2 papers), Epigenetics and DNA Methylation (2 papers), RNA Interference and Gene Delivery (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Cell Biology (260 citations), Cancer Research (92 citations) and Molecular Biology (416 citations). Sweta Srivastava has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Cecil Ross, Johanne Matheson, Andrew B. Fielding, Rytis Prekeris, Xinzi Yu, Stephen A. Baldwin, Gilles R.X. Hickson, Gwyn W. Gould, Eric Schonteich and Sudhir Krishna. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Cancer Research, British Journal of Cancer, IET Nanobiotechnology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.